These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23025545)

  • 1. Redox and nitrosative regulation of cardiac remodeling.
    Kass DA; Shah AM
    Antioxid Redox Signal; 2013 Mar; 18(9):1021-3. PubMed ID: 23025545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.
    Seddon M; Looi YH; Shah AM
    Heart; 2007 Aug; 93(8):903-7. PubMed ID: 16670100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease.
    Elahi MM; Naseem KM; Matata BM
    FEBS J; 2007 Feb; 274(4):906-23. PubMed ID: 17244198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapy.
    Tang WH; Francis GS
    Curr Cardiol Rep; 2004 May; 6(3):200-4. PubMed ID: 15075056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
    Toblli JE; Cao G; Rivas C; Giani JF; Dominici FP
    Int J Cardiol; 2016 Jun; 212():84-91. PubMed ID: 27038710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies.
    Hansen T; Galougahi KK; Celermajer D; Rasko N; Tang O; Bubb KJ; Figtree G
    Pharmacol Ther; 2016 Sep; 165():50-62. PubMed ID: 27216365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cardiovascular cellular processes by S-nitrosylation.
    Schulman IH; Hare JM
    Biochim Biophys Acta; 2012 Jun; 1820(6):752-62. PubMed ID: 21536106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.
    Varga ZV; Giricz Z; Liaudet L; Haskó G; Ferdinandy P; Pacher P
    Biochim Biophys Acta; 2015 Feb; 1852(2):232-42. PubMed ID: 24997452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of NADPH oxidases in cardiac remodelling and heart failure.
    Sirker A; Zhang M; Murdoch C; Shah AM
    Am J Nephrol; 2007; 27(6):649-60. PubMed ID: 17901689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure.
    Khaper N; Bryan S; Dhingra S; Singal R; Bajaj A; Pathak CM; Singal PK
    Antioxid Redox Signal; 2010 Oct; 13(7):1033-49. PubMed ID: 20380580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase in left ventricular remodeling and heart failure.
    Shastry S; Hayden MR; Lucchesi PA; Tyagi SC
    Curr Cardiol Rep; 2003 May; 5(3):200-4. PubMed ID: 12691636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of ventricular remodeling: role of the myocyte.
    Li F; Wang X; Yi XP; Gerdes AM
    Curr Heart Fail Rep; 2004; 1(1):5-8. PubMed ID: 16036018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies.
    Takano H; Hasegawa H; Nagai T; Komuro I
    Intern Med; 2003 Jun; 42(6):465-9. PubMed ID: 12857042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Kourea K; Andreadou I; Ikonomidis I; Markantonis S; Ioannidis K; Paraskevaidis I; Iliodromitis E; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Apr; 103(8):1134-8. PubMed ID: 19361602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New targets to treat the structural remodeling of the myocardium.
    González A; Ravassa S; Beaumont J; López B; Díez J
    J Am Coll Cardiol; 2011 Oct; 58(18):1833-43. PubMed ID: 22018293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress.
    Klatt P; Lamas S
    Eur J Biochem; 2000 Aug; 267(16):4928-44. PubMed ID: 10931175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics.
    Dalle-Donne I; Scaloni A; Giustarini D; Cavarra E; Tell G; Lungarella G; Colombo R; Rossi R; Milzani A
    Mass Spectrom Rev; 2005; 24(1):55-99. PubMed ID: 15389864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a hyper-reductive redox in a sub-set of heart failure patients.
    Sairam T; Patel AN; Subrahmanian M; Gopalan R; Pogwizd SM; Ramalingam S; Sankaran R; Rajasekaran NS
    J Transl Med; 2018 May; 16(1):130. PubMed ID: 29776421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical and structural remodeling of the failing ventricle.
    Armoundas AA; Wu R; Juang G; Marbán E; Tomaselli GF
    Pharmacol Ther; 2001; 92(2-3):213-30. PubMed ID: 11916538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in heart failure: what are we missing?
    Sawyer DB
    Am J Med Sci; 2011 Aug; 342(2):120-4. PubMed ID: 21747279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.